| Database ID | Agent | Target | Cancer Type | Detail |
| DB00331 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00332 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00333 | nimotuzumab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00334 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00335 | nimotuzumab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00336 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00337 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00338 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00339 | cetuximab | Epidermal growth factor receptor | advanced solid tumors | view |
| DB00340 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00341 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00342 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00343 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00344 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00345 | cetuximab | Epidermal growth factor receptor | advanced solid tumors | view |